Search results
Results from the WOW.Com Content Network
Phenylacetone, also known as phenyl-2-propanone, is an organic compound with the chemical formula C 6 H 5 CH 2 COCH 3. It is a colorless oil that is soluble in organic solvents. It is a mono-substituted benzene derivative, consisting of an acetone attached to a phenyl group. As such, its systematic IUPAC name is 1-phenyl-2-propanone.
We’ve outlined all the steps and supplies needed to create your own super-liquid below, but be sure to watch the full tutorial above. Supplies you need: Shop: Washable Tempera Paint , $20.02 ...
Propiophenone can be prepared by Friedel–Crafts reaction of propanoyl chloride and benzene.It is also prepared commercially by ketonization of benzoic acid and propionic acid over calcium acetate and alumina at 450–550 °C: [1]
3,4-Methylenedioxyphenylpropan-2-one [1] or piperonyl methyl ketone (MDP2P or PMK) is a chemical compound consisting of a phenylacetone moiety substituted with a methylenedioxy functional group. It is commonly synthesized from either safrole (which, for comparison, is 3-[3,4-(methylenedioxy)phenyl]-2-propene) or its isomer isosafrole via ...
Synthesis is relatively simple but entails risk with flammable and corrosive chemicals, particularly the solvents used in extraction and purification. The six major routes of production begin with either phenyl-2-propanone (P2P) or with one of the isomeric compounds pseudoephedrine and ephedrine. [95]
Air-free techniques refer to a range of manipulations in the chemistry laboratory for the handling of compounds that are air-sensitive. These techniques prevent the compounds from reacting with components of air , usually water and oxygen ; less commonly carbon dioxide and nitrogen .
It is a common method to make amines and is widely used in green chemistry since it can be done catalytically in one-pot under mild conditions. In biochemistry, dehydrogenase enzymes use reductive amination to produce the amino acid glutamate .
A mere 2.5 percent of all primary care doctors have gone through the certification process. “I cannot say it enough,” said then-Sen. Carl Levin (D-Mich.) at the meeting. “Unless primary care physicians can identify the disease of addiction and know how to intervene, we will make slower progress than we should,” Levin said.